Scholars Central

Conference abstractPublished 27 Apr 2015

Modern trends in stem cell technologies as applicable to ischemic heart diseases

Authors: Sergey Suchkov, Matt Springer, Yuri Belov, Eduard Charchyan, Dmitrii Kostyushev, Jeroen Essers

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cardiovascular atherosclerotic and ischemic diseases constitute the leading cause of morbidity and mortality throughout middle- and high-income countries since following significant injury, the heart undergoes induced compensation and gradually deteriorates towards impending heart failure. But current and canonical therapy slows and does not halt the resultant adverse remodel-ing. So, novel therapeutic strategies are required to protect the heart from acute attacks in order to reduce myocardial infarction size, preserve cardiac function and improve clinical outcomes in patients with ischemic heart diseases. And the discovery of coronary risk factors and targets of newer generations have led to the development of personalized cardiology whilst providing the basis for prevention of atheroscleroticvascular disease. For instance, myocardial infarction (MI) is accompanied by a significant loss of cardiac myocytes (CMs) which, in turn, differentiated from human embryonic stem cells (hESCs), offer a potentially unlimited cell source for cardiac disease therapies and regenerative cardiovascular medicine. So, successful use of SC therapy in the prevention and treatment of heart failure fol-lowing cardiac infarction is so much promising! For instance, the putative endothelial progenitor cells (EPCs) can efficiently promote angiogene-sis and restore perfusion of ischemic tissues whilst representing a biomarker to guide preventive or therapeutic interventions in this disease. A recently discovered cell source for cardiac repair has emerged as a result of a breakthrough reprogramming somatic cells to induced pluripotent stem cells (iPSCs). Preclinical studies using a variety of cell preparations generated from iPSCs have shown great evidence of cardiac repair. The cells mentioned derived from thepatient?s own cell types, including fibroblasts, have become particularly attractive. Moreover, mesenchymalSC (MSC) transplantation would be a promising new therapy to improve cardiac function after MI whilst ameliorating interstitial fibrosis and the remodeling of gap junction as well as attenuating focal heterogeneity of repolarization. Meanwhile, today signaling pathways that regulate pluripotencyand secreted soluble factors as key players in communication to local and distant tissueshave been the major focus of SCtranslational research as applicable to cardiology. For example, actively secreted membrane vesicles, including exosomes, are being recognized as new candidates with important roles in in-tercellular and tissue-level communication. We would critically assess the emerging role of exosomes in local and distant communicative mechanisms after MI. A comprehensive under-standing of the role of exosomes in postinfarctioncardiac repair could bridge a major gap in knowledge of the repair mechanism after myocardial injury.Thus SC-based therapy can become a realistic option in regenerative processes for replacing lost cells and reconstituting the damaged organ, as before. Meanwhile treatment of heart failure, although greatly improved, remains a big challenge. And, to our mind, new promising therapeutic strategies for cardiac protection would have to include novel aspects of mitochondrial function, epigenetics, the immune system, growth factors, and SC therapyin terms of targeting and clinical application, in particular!. It is likely that in the future, a greater emphasis will be placed on prevention.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical and Experimental Cardiology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical and Experimental Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “Sergey Suchkov”
  • BylineArticles whose byline prints “Matt Springer”
  • BylineArticles whose byline prints “Yuri Belov”
  • BylineArticles whose byline prints “Eduard Charchyan”
  • BylineArticles whose byline prints “Dmitrii Kostyushev”
  • BylineArticles whose byline prints “Jeroen Essers”